Imaging Biochemical Recurrence in Prostate Cancer

Comment

Gary D Luker. Radiol Imaging Cancer. 2021 Jul.

. 2021 Jul;3(4):e219015.

doi: 10.1148/rycan.2021219015.

No abstract available

Comment on

Diagnostic Performance of ¹⁸F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.
Morris MJ, Rowe SP, Gorin MA, Saperstein L, Pouliot F, Josephson D, Wong JYC, Pantel AR, Cho SY, Gage KL, Piert M, Iagaru A, Pollard JH, Wong V, Jensen J, Lin T, Stambler N, Carroll PR, Siegel BA; CONDOR Study Group. Morris MJ, et al. Clin Cancer Res. 2021 Jul 1;27(13):3674-3682. doi: 10.1158/1078-0432.CCR-20-4573. Epub 2021 Feb 23. Clin Cancer Res. 2021. PMID: 33622706 Free PMC article. Clinical Trial.

1. Morris MJ, Rowe SP, Gorin MA, et al. . Diagnostic performance of 18F-DCFPyL-PET/CT in men with biochemically recurrent prostate cancer: results from the CONDOR Phase III, multicenter study. Clin Cancer Res 2021;27(13):3674–3682. doi:10.1158/1078-0432.CCR-20-4573 - PMC - PubMed